2022/11/04 IR News Consolidated Financial Report for the First Half of the Fiscal Year Ending March 31, 2023
2022/09/26 IR News UBE Corporation Announces It Will Record a Share of the Loss of Entities Accounted for Using Equity Method (Non-Operating Loss) PDF (PDF:130KB)
2022/09/26 News Release Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
2022/08/04 IR News (Presentation and Q&A Transcript) Telephone Conference for the First Quarter of FY2022 Consolidated Result
2022/08/04 IR News Consolidated Financial Report for the First Quarter of the Fiscal Year Ending March 31, 2023
2022/07/28 IR News Notice Regarding Completion of Payment for Disposal of Treasury Stock as Restricted Stock Remuneration
2022/07/06 News Release UBE Corporation to Begin Basic Design for DMC and EMC Plant Construction in the U.S.
